APA

Fontaine H., Kahi S., Chazallon C., Bourgine M., Varaut A., Buffet C., Godon O., Meritet J. F., Saïdi Y., Michel M. L., Scott-Algara D., Aboulker J. P. & Pol S. (20150218). Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN. : Gut.

Chicago

Fontaine H, Kahi S, Chazallon C, Bourgine M, Varaut A, Buffet C, Godon O, Meritet J F, Saïdi Y, Michel M L, Scott-Algara D, Aboulker J P and Pol S. 20150218. Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN. : Gut.

Harvard

Fontaine H., Kahi S., Chazallon C., Bourgine M., Varaut A., Buffet C., Godon O., Meritet J. F., Saïdi Y., Michel M. L., Scott-Algara D., Aboulker J. P. and Pol S. (20150218). Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN. : Gut.

MLA

Fontaine H, Kahi S, Chazallon C, Bourgine M, Varaut A, Buffet C, Godon O, Meritet J F, Saïdi Y, Michel M L, Scott-Algara D, Aboulker J P and Pol S. Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN. : Gut. 20150218.